From Amarin
Amarin (AMRN) announced the U.S. FDA has approved a new indication and label expansion for Vascepa® (icosapent ethyl) capsules. According to Amarin’s press release, with this label expansion approval, Vascepa has become . . .
This content is for paid subscribers.
Today’s Highlights
December 16, 2019
